【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Zenpep/ Ultresa/ Ultrase/ Ultrase MT
04.1.2 Colomycin/ Colobreathe
04.1.3 Pulmozyme
04.1.4 Cayston
04.1.5 TOBI/ TOBI Podhaler
04.1.6 Kalydeco
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Pathophysiology
07.3 Epidemiology
07.3.1 Global
07.3.2 North America
07.3.3 Europe
07.3.4 Africas
07.3.5 Latin America
07.3.6 Middle East
07.3.7 Asia and Oceania
07.4 Diagnosis
07.4.1 Newborn Screening
07.4.2 Carrier Testing
07.4.3 Antenatal Testing
07.4.4 Other Tests
07.5 Manifestations of Cystic Fibrosis
07.6 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Molecule Type
09.1 Biologics
09.1.1 Enzymes
09.2 Small Molecules
09.2.1 CFTR Modulator
09.2.2 Antibiotics
10.Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
10.3 Topical
11.Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
12.Geographical Segmentation
12.1 Cystic Fibrosis Market in the Americas
12.1.1 Cystic Fibrosis Market in the US
12.1.2 Cystic Fibrosis Market in the Latin America
12.1.3 Cystic Fibrosis Market in the Canada
12.2 Cystic Fibrosis Market in the EMEA Region
12.2.1 Market Size and Forecast
12.3 Cystic Fibrosis Market in the APAC Region
12.3.1 Market Size and Forecast
13.Key Leading Countries
13.1 US
13.2 UK
13.3 France
13.4 Canada
13.5 Italy
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 F. Hoffmann-La Roche
21.2.2 Novartis
21.2.3 Vertex Pharmaceuticals
21.2.4 Actavis
21.2.5 Gilead Sciences
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
21.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.1.9 SWOT Analysis
22.3 Gilead Sciences
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Description
21.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 Vertex Pharmaceuticals
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot Of Cystic Fibrosis Disease
Exhibit 3: Defects Caused by CFTR Mutation
Exhibit 4: Epidemiology of Cystic Fibrosis in the World 2012
Exhibit 5: Prevalence of Cystic Fibrosis by Country 2014
Exhibit 6: Prevalence Number of Cystic Fibrosis by Country 2014
Exhibit 7: Snapshot of US Prevalence of Cystic Fibrosis 2014
Exhibit 8: Forecast of Cystic Fibrosis Prevalence in US 2014-2019
Exhibit 9: Epidemiology Based on the Education Level in US, 2011
Exhibit 10: Epidemiology based on the Marital Status in US, 2011
Exhibit 11: Epidemiology based on the Employment Status in US, 2011
Exhibit 12: Forecast of Cystic Fibrosis Prevalence in Canada 2014-2019
Exhibit 13: Forecast of Cystic Fibrosis Prevalence in the UK 2014-2019
Exhibit 14: Age Distribution at Death for Cystic Fibrosis Patients in UK, 2013
Exhibit 15: Age Distribution by Gender for Cystic Fibrosis Patients in the UK, 2013
Exhibit 16: Age Distribution by Sex for Cystic Fibrosis Patients in the UK, 2013
Exhibit 17: Diagnosis of Cystic Fibrosis
Exhibit 18: The Manifestations of Cystic Fibrosis
Exhibit 19: Snapshot of the Economic Burden of Cystic Fibrosis
Exhibit 20: Snapshot of Global Cystic Fibrosis Market 2014
Exhibit 21: Global Cystic Fibrosis Market 2014-2019 (US$ million)
Exhibit 22: Global Cystic Fibrosis Market Segmentation By Class of Drugs
Exhibit 23: Global Cystic Fibrosis Drugs Market Segmentation by Molecule Type 2014
Exhibit 24: Global Cystic Fibrosis Market Segmentation By Route Of Administration
Exhibit 25: Global Cystic Fibrosis Drugs Market Segmentation by Route of Administration 2014
Exhibit 26: Global Cystic Fibrosis Market Segmentation by Dosage Form
Exhibit 27: Global Cystic Fibrosis Drugs Market Segmentation by Dosage Form 2014
Exhibit 28: Global Cystic Fibrosis Market by Geographical Segmentation 2014 and 2019
Exhibit 29: Global Cystic Fibrosis Market Revenue by Geographical Segmentation 2014-2019 (US$ million)
Exhibit 30: Global Cystic Fibrosis Market Growth Rate by Region 2014-2019
Exhibit 31: Revenue (US$ million) and CAGR of Global Cystic Fibrosis Market by Geographical Segments 2014 and 2019
Exhibit 32: Global Cystic Fibrosis Market by Country/Region 2014
Exhibit 33: Global Cystic Fibrosis Market by Country/Region 2014 (US$ million)
Exhibit 34: Cystic Fibrosis Market in the Americas 2014-2019 (US$ million)
Exhibit 35: Cystic Fibrosis Market Revenue in the Americas 2014-2019
Exhibit 36: Cystic Fibrosis Market Growth Rate in the Americas 2014-2019
Exhibit 37: Cystic Fibrosis Market in the Americas by Region 2014 and 2019
Exhibit 38: Revenue (US$ million) and CAGR of Cystic Fibrosis Market in the Americas by Regions 2014 and 2019
Exhibit 39: Cystic Fibrosis Market in the US 2014-2019 (US$ million)
Exhibit 40: Cystic Fibrosis Market in the Latin America 2014-2019 (US$ million)
Exhibit 41: Cystic Fibrosis Market in Canada 2014-2019 (US$ million)
Exhibit 42: Cystic Fibrosis Market in EMEA 2014-2019 (US$ million)
Exhibit 43: Cystic Fibrosis Market in EMEA by Country/Region 2014
Exhibit 44: Cystic Fibrosis Market in APAC 2014-2019 (US$ million)
Exhibit 45: Buying Criteria of Global Cystic Fibrosis Market
Exhibit 46: Global Cystic Fibrosis Market Share Analysis 2014
Exhibit 47: Global Sales Comparison of Pulmozyme 2013 vs 2012 (US$ Million)
Exhibit 48: Quarterly Sales Comparison of Pulmozyme in the US 1994-2008 (US$ Million)
Exhibit 49: Quarterly Sales Comparison of Pulmozyme Sales to Collaborators 1997-2008 (US$ Million)
Exhibit 50: Quarterly Sales Comparison of Pulmozyme Total Sales 1994-2008 (US$ Million)
Exhibit 51: Total Global Sales Comparison of Pulmozyme 1994-2008 (US$ Million)
Exhibit 52: TOBI Podhaler
Exhibit 53: YoY Sales Comparison of TOBI and TOBI Podhaler 2006-2013 (US$ Million)
Exhibit 54: YoY Sales Comparison of Kalydeco 2012-2013 (US$ Million)
Exhibit 55: Actavis: Business Segmentation 2014
Exhibit 56: Actavis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 57: Actavis : Sales by Geography (in US$ million)
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2013 and 2014
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Diagnostics Division)
Exhibit 63: Gilead Sciences: Business Segmentation by Revenue 2014
Exhibit 64: Gilead Sciences: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Gilead Sciences: Sales by Geography 2014
Exhibit 18: Novartis AG: Business Segmentation
Exhibit 19: Novartis AG: Revenue by Business Segmentation 2014
Exhibit 20: Novartis AG: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Novartis AG: Revenue by Geographical Segmentation 2014
Exhibit 63: Vertex Pharmaceuticals: Business Segmentation by Revenue 2014
Exhibit 64: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Vertex Pharmaceuticals: Sales by Geography 2014
【レポート販売概要】
■ タイトル:嚢胞性線維症(CF症)治療薬の世界市場■ 英文:Global Cystic Fibrosis Market 2015-2019
■ 発行日:2014年12月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4842
■ 調査対象地域:グローバル
- 交通安全(Road Safety)のグローバル市場動向(2014-2019)Road safety market report constitutes of various types, systems, devices and technologies, services and regions. The overall market size is calculated by adding up the market size of various systems/ devices and technologies and services. MarketsandMarkets forecasts that urban roads safety market would continue to account for the biggest market share during the forecast period. However, the highwa …
- 世界の低公害車(低排出ガス車)市場動向(2012-2016)TechNavio's analysts forecast the Global Low Emission Vehicle market to grow at a CAGR of 30.65 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in initiatives from governments across the world promoting low emission vehicles. The Global Low Emission Vehicle market has also been witnessing a reduction in the price of vehicle batteries in …
- Range Resources Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 液化天然ガス用インフラの世界市場:LNG液化設備、LNG再ガス化設備There are a number of exciting LNG liquefaction prospects around the world in 2015, both under construction and prospective. The question is whether the demand of East Asia is strong enough to support the economics of an abundant supply of liquefaction opportunities. This report tackles that question, forecasting the feasibility and likelihood of further liquefaction and regasification investment …
- 使い捨てバイオリアクターの世界市場:波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクターDeveloping markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion’s share of the global SUB market, by molecule type. However, the stem ce …
- 肉種判別検査の世界市場予測(~2022):種別(ウシ、イノシシ、ニワトリ、ウマ、ヒツジ)、技術別(ポリメラーゼ連鎖反応PCR、ELISA、分子診断)、形態別(未加工、調理済、加工済)、地域別“The meat speciation testing market projected to grow at a CAGR of 8.20%”The meat speciation testing market is projected to reach 2,220.6 million by 2022 at a CAGR of 8.20% from 2016. The market is driven by factors such as increase in number of adulteration and food fraud cases, religious beliefs, compliance with labeling laws, and stringent regulations and consumer demand for certified products. …
- LCDパネル用バックライトユニットの世界市場About LCD Backlight Unit An LCD backlight unit forms a significant component of an LCD display device. It provides illumination for the projection of an image on the screen. LCDs do not produce light; therefore, backlight units act as a light source for displaying the image. Three major types of backlight units used for illuminating LCDs are cold-cathode fluorescent lamp (CCFL), white-edge light-e …
- 世界主要国におけるHIV/AIDS検査市場2015The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIV Ag, HTLV-I/II, Western Blot and other confirmatory …
- ラベルフリー検出の世界市場:技術(表面プラスモン共鳴、バイオレイヤー干渉法)、製品(消耗品、マイクロプレート、バイオセンサーチップ)、用途、地域別分析The global label-free detection market is expected to grow at a CAGR of 11.86% between 2015 and 2020, to reach USD 2.13 Billion in 2020. Label-free detection is rapidly gaining widespread acceptance as a research and development tool in the pharmaceutical and biotech industry and academic research. It helps in the investigation of biomolecular interactions without auto-fluorescent, spatial-interfe …
- Ankylosing Spondylitis (Bekhterev’s Disease):グローバル臨床試験レビューH1, 2013Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2013" provides data on the Ankylosing Spondylitis (Bekhterev’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ankylo …
- 北米の包装機械市場About packaging equipment Packaging equipment refers to machinery used for packaging products before they are dispatched for storage and distribution. Packaging is considered an important part of marketing as it has a strong impact on customers’ buying decision. Packaging equipment is widely used for filling, labeling, coding, and wrapping of products Technavio's analysts forecast the packaging eq …
- コイルドチュービング装置・サービスの世界市場This report estimates the coiled tubing services market in terms of value in $million. This has been broken down into component regions and further split into countries. A Coil Tubing unit usually comprises a set of equipment to perform standard continuous-length tubing operations in the oil and gas fields. Coiled tubes are generally made of low-alloy carbon-steel and range from 0.75 inches to 4 i …
- 高機能ファブリックの世界市場:コーティング布、ポリアミド、ポリエステル、複合ファブリック、アラミドThe performance fabric market is projected to reach 79.55 Billion by 2020, registering a CAGR of 4.8% between 2015 and 2020. Increasing awareness regarding personal hygiene and physical fitness and advancement in performance fabric production technology are the major drivers of the market. The performance fabrics market is witnessing high growth on account of increasing demand from industrial, def …
- 北米の貯水装置市場予測(~2020)The North America water storage systems market was valued at USD 2.45 Billion in 2014 and is expected to reach USD 4.14 Billion by 2020, at a CAGR of 9.1% from 2015 to 2020. Growing population, scarcity of clean water, and growing industrial activities are factors driving the market of water storage systems in North America. Among the various materials that are used to construct water storage syst …
- スタンドアップ型ポーチの世界市場:無菌性ポーチ、標準型ポーチ、レトルトポーチStand-up pouches have attracted a number of customers that have led to their wide adoption by end-users worldwide for different applications. Producers can very easily customize the shape, size and provide the buyer with additional features, as per the product requirements. Stand-up pouches consume less store capacity and have ability to stand up on shelves, thus adding up to the product’s visibil …